Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes

被引:119
作者
Rittig, MG [1 ]
Kaufmann, A
Robins, A
Shaw, B
Sprenger, H
Gemsa, D
Foulongne, V
Rouot, B
Dornand, J
机构
[1] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England
[2] Univ Nottingham, Sch Med, Sch Clin Lab Sci, Nottingham NG7 2UH, England
[3] Univ Montpellier 2, INSERM U431, F-34095 Montpellier, France
[4] Univ Marburg, Inst Immunol, D-35032 Marburg, Germany
关键词
phagocytosis; intracellular trafficking; intracellular parasitism; host-pathogen interaction;
D O I
10.1189/jlb.0103015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Virulence of the intracellular pathogen Brucella for humans is mainly associated with its lipopolysaccharide (LPS) phenotype, with smooth LPS phenotypes generally being virulent and rough ones not. The reason for this association is not quite understood. We now demonstrate by flow cytometry, electron microscopy, and ELISA that human peripheral blood monocytes interact both quantitatively and qualitatively different with smooth and rough Brucella organisms in vitro. We confirm that considerably higher numbers of rough than smooth brucellae attach to and enter the monocytes in nonopsonic conditions; but only smooth brucellae replicate in the host cells. We show for the first time that rough brucellae induce higher amounts than smooth brucellae of several CXC (GRO-alpha, IL-8) and CC (MIP-1alpha, MIP-1beta, MCP-1, RANTES) chemokines, as well as pro(IL-6, TNF-alpha) and anti-inflammatory (IL-10) cytokines released by challenged monocytes. Upon uptake, phagosomes containing rough brucellae develop selective fusion competence to form spacious communal compartments, whereas phagosomes containing smooth brucellae are nonfusiogenic. Collectively, our data suggest that rough brucellae attract and infect monocytes more effectively than smooth brucellae, but only smooth LPS phenotypes establish a specific host cell compartment permitting successful parasitism. These novel findings link the LPS phenotype of Brucella and its virulence for humans at the level of the infected host cells. Whether this is due to a direct effect of the LPS molecules or to upstream bacterial mechanisms remains to be established. J. Leukoc. Biol. 74: 1045-1055; 2003.
引用
收藏
页码:1045 / 1055
页数:11
相关论文
共 64 条
[1]   Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival [J].
Allen, CA ;
Adams, LG ;
Ficht, TA .
INFECTION AND IMMUNITY, 1998, 66 (03) :1008-1016
[2]   Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages [J].
Allen, LAH ;
Schlesinger, LS ;
Kang, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :115-127
[3]  
ANDERSON TD, 1986, AM J PATHOL, V124, P226
[4]   The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages [J].
Antoine, JC ;
Prina, E ;
Lang, T ;
Courret, N .
TRENDS IN MICROBIOLOGY, 1998, 6 (10) :392-401
[5]   Intracellular trafficking of Brucella abortus in J774 macrophages [J].
Arenas, GN ;
Staskevich, AS ;
Aballay, A ;
Mayorga, LS .
INFECTION AND IMMUNITY, 2000, 68 (07) :4255-4263
[6]   Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic [J].
Baorto, DM ;
Gao, ZM ;
Malaviya, R ;
Dustin, ML ;
vanderMerwe, A ;
Lublin, DM ;
Abraham, SN .
NATURE, 1997, 389 (6651) :636-639
[7]   BINDING OF BACTERIA FROM THE GENUS BRUCELLA TO HUMAN LYMPHOCYTES-B [J].
BRATESCU, A ;
MAYER, EP ;
TEODORESCU, M .
INFECTION AND IMMUNITY, 1981, 31 (02) :816-821
[8]   MECHANISMS OF BINDING OF BRUCELLA-ABORTUS TO MONONUCLEAR PHAGOCYTES FROM COWS NATURALLY RESISTANT OR SUSCEPTIBLE TO BRUCELLOSIS [J].
CAMPBELL, GA ;
ADAMS, LG ;
SOWA, BA .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 41 (3-4) :295-306
[9]   Structural and functional analyses of bacterial lipopolysaccharides [J].
Caroff, M ;
Karibian, D ;
Cavaillon, JM ;
Haeffner-Cavaillon, N .
MICROBES AND INFECTION, 2002, 4 (09) :915-926
[10]  
Caron E, 1996, J IMMUNOL, V156, P2885